Bonus BioGroup Ltd. Logo

Bonus BioGroup Ltd.

A clinical-stage biotech firm developing cell therapy and tissue engineering products.

BONS | TA

Overview

Corporate Details

ISIN(s):
IL0004850116
LEI:
Country:
Israel
Address:
Park P.O.B 15143, 31905 Haifa

Description

Bonus BioGroup Ltd. is a clinical-stage biotechnology company that develops cell therapy and tissue engineering products. The company's research focuses on addressing unmet medical needs related to tissue damage, inflammation, and immune response. Its core technology platforms include an investigational cell therapy designed to modulate inflammation and promote tissue repair using mesenchymal cells, and a viable tissue engineering approach that combines patient-derived cells with biomaterials for bone regeneration. Key product candidates in its pipeline are BonoFill, a personalized, tissue-engineered bone graft for orthopedic and maxillofacial defects, and MesenCure, an allogeneic cell therapy developed to target inflammation and tissue damage. These investigational therapies are currently being evaluated in clinical trials for safety and efficacy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 11:48
Company Presentation- 2025
Hebrew (modern) 9.0 MB
2025-05-27 11:48
Company Presentation- 2025
Russian 43.6 KB
2023-07-11 12:06
Company Presentation, July 2023
English 3.4 MB
2023-07-11 12:06
Company Presentation, July 2023
Russian 44.7 KB
2022-04-11 16:02
Company Presentation
English 8.2 MB
2022-04-11 16:02
Company Presentation
Russian 47.1 KB
2022-04-11 15:01
Company Presentation
Hebrew (modern) 11.0 MB
2022-04-11 15:01
Company Presentation
Russian 47.1 KB
2022-01-10 10:52
The company inteds to publish an immediate report, trading will be open after …
Hebrew (modern) 105.1 KB

Automate Your Workflow. Get a real-time feed of all Bonus BioGroup Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonus BioGroup Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonus BioGroup Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Genprex, Inc. Logo
Clinical-stage gene therapy company developing therapies for cancer and diabetes.
United States of America
GNPX
Genxone Spolka Akcyjna Logo
A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.
Poland
GX1
GeoVax Labs, Inc. Logo
Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.
United States of America
GOVX
GH Research PLC Logo
Develops mebufotenin-based therapies for psychiatric and neurological disorders.
United States of America
GHRS
GI Innovation Inc. Logo
Researches and develops protein-based drugs for immuno-oncology and immunology.
South Korea
358570
Ginkgo Bioworks Holdings, Inc. Logo
Operates a horizontal platform for cell programming and synthetic biology.
United States of America
DNA
GRAIL, Inc. Logo
A healthcare company developing blood tests for multi-cancer early detection.
United States of America
GRAL
GT Biopharma, Inc. Logo
Clinical-stage immuno-oncology company developing therapies with its NK cell engager tech.
United States of America
GTBP
Guard Therapeutics International AB Logo
Clinical-stage biotech developing therapies to prevent acute kidney injury.
Sweden
GUARD
Gubra A/S Logo
Biotech and CRO focused on peptide drugs for metabolic and fibrotic diseases.
Denmark
GUBRA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.